M ElHefnawi, M Abdalla, S Ahmed, W Elakel… - 2012 IEEE/ACM … - infona.pl
Hepatitis C virus' patients with genotypes 1 & 4 have break-even response rates to Pegylated-Interferon (Peg-IFN) and Ribavirin (RBV) treatment. Furthermore, the …
M ElHefnawi, M Abdalla, S Ahmed, W Elakel… - Proceedings of the …, 2012 - dl.acm.org
Hepatitis C virus' patients with genotypes 1 & 4 have break-even response rates to Pegylated-Interferon (Peg-IFN) and Ribavirin (RBV) treatment. Furthermore, the …
M ElHefnawi, M Abdalla, S Ahmed, W Elakel, G Esmat… - researchgate.net
Hepatitis C virus' patients with genotypes 1 & 4 have break-even response rates to Pegylated-Interferon(Peg-IFN) and Ribavirin (RBV) treatment. Furthermore, the …
M ElHefnawi, M Abdalla, S Ahmed, W Elakel… - 2012 IEEE/ACM …, 2012 - computer.org
Hepatitis C virus' patients with genotypes 1 & 4 have break-even response rates to Pegylated-Interferon (Peg-IFN) and Ribavirin (RBV) treatment. Furthermore, the …
M ElHefnawi, M Abdalla, S Ahmed, W Elakel, G Esmat… - academia.edu
Hepatitis C virus' patients with genotypes 1 & 4 have break-even response rates to Pegylated-Interferon(Peg-IFN) and Ribavirin (RBV) treatment. Furthermore, the …
M ElHefnawi, M Abdalla, S Ahmed, W Elakel, G Esmat… - academia.edu
Hepatitis C virus' patients with genotypes 1 & 4 have break-even response rates to Pegylated-Interferon(Peg-IFN) and Ribavirin (RBV) treatment. Furthermore, the …